Plant-based Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for plant-based vaccines. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights: Plant-based Vaccines Market

Plant-based Vaccines Market Size (2024E): USD 1.63 Billion
Projected Market Value (2032F): USD 3.00 Billion
Global Market Growth Rate (CAGR 2024 to 2032): 7.9%

Plant-based Vaccines Market - Report Scope:

Plant-based vaccines are emerging as a promising alternative to traditional vaccine production methods. Utilizing plants such as tobacco, maize, and others as bioreactors for vaccine production offers scalability, cost-effectiveness, and rapid response capabilities to emerging infectious diseases. The plant-based vaccines market caters to pharmaceutical companies, biotechnology firms, and research institutions, offering a range of vaccine types targeting various diseases including influenza, COVID-19, and other infectious diseases.

Market Growth Drivers:

The global plant-based vaccines market is driven by several factors, including the increasing demand for efficient vaccine production platforms, the need for rapid response to pandemics, and advancements in plant biotechnology enhancing vaccine yield and efficacy. Growing investments in biopharmaceutical research and development further propel market expansion, alongside regulatory support for plant-derived pharmaceuticals and vaccines.

Market Restraints:

Despite growth prospects, the plant-based vaccines market faces challenges related to regulatory approvals, scalability issues in large-scale production, and public acceptance of plant-derived vaccines compared to conventional methods. Technical complexities in optimizing plant expression systems and ensuring consistent vaccine quality pose operational challenges for market players.

Market Opportunities:

The plant-based vaccines market presents significant growth opportunities driven by advancements in plant genetic engineering, expanding vaccine pipeline targeting various diseases, and increasing partnerships between pharmaceutical companies and biotech firms to leverage plant-based platforms for vaccine development. Strategic collaborations, technology licensing, and expansion into emerging markets are key strategies to capitalize on growth opportunities in the evolving landscape of plant-based vaccines.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the plant-based vaccines market globally?
Which plant species and bioreactor technologies are driving vaccine production and innovation?
How are advancements in plant biotechnology reshaping the competitive landscape of the plant-based vaccines market?
Who are the key players contributing to the plant-based vaccines market, and what strategies are they employing to maintain market leadership?
What are the emerging trends and future prospects in the global plant-based vaccines market?

Competitive Intelligence and Business Strategy:

Leading players in the global plant-based vaccines market, including iBio, Medicago Inc., and Creative Biolabs, focus on innovation, strategic partnerships, and capacity expansion to gain a competitive edge. These companies invest in research and development to optimize plant expression systems, enhance vaccine yields, and broaden their product portfolios targeting various infectious diseases. Collaborations with academic institutions and government agencies facilitate technology transfer and regulatory approvals, supporting market penetration and global vaccine supply.

Key Companies Profiled:

Creative Biolabs
Medicago Inc.
iBio
ICON
EEA Consulting Engineers
Kentucky BioProcessing, Inc.
Baiya Phytopharm
Protalix Biotherapeutics

Key Segments of Plant-Based Vaccines Industry Research

By Type:

Viral Vaccines
Bacterial Vaccines

By Application:

Influenza
Zika Virus
Ebola Virus

By Source:

Maize
Tobacco
Potatoes

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Product Code: PMRREP27961

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends

4. Key Success Factors

4.1. Promotional Strategies, By Key Manufacturers
4.2. Key Regulations
4.3. Product Pipeline
4.4. Reimbursement Scenario
4.5. Value Chain Analysis
4.6. PESTEL Analysis
4.7. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure Outlook
- 5.1.3. Global Recombinant Vaccines Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Cost of Production
- 5.2.2. Growing Development of Recombinant Vaccines
- 5.2.3. Increasing Incidence of Zoonotic Diseases
- 5.2.4. Rising Research and Development Activities
- 5.2.5. Growing Marketing Approvals for Plant-Based Vaccines
- 5.2.6. Cost of Vaccines
- 5.2.7. Emergence of the COVID-19 Pandemic
- 5.2.8. Large Clinical Pipeline
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Source
- 6.1.2. By Type
- 6.1.3. By Application
- 6.1.4. By Country
6.2. 2024 Market Scenario

7. Global Plant-Based Vaccines Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2032

7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032, By Source

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Source, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Source, 2024-2032
- 8.3.1. Maize
- 8.3.2. Tobacco
- 8.3.3. Potato
- 8.3.4. Others
8.4. Market Attractiveness Analysis By Source

9. Global Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032, By Type

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Type , 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Type, 2024-2032
- 9.3.1. Viral Vaccine
- 9.3.2. Bacterial Vaccine
- 9.3.3. Others
9.4. Market Attractiveness Analysis By Type

10. Global Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032, By Application

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2032
- 10.3.1. Influenza
- 10.3.2. Zika Virus
- 10.3.3. Ebola Virus
- 10.3.4. Others
10.4. Market Attractiveness Analysis By Application

11. Global Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032, By Region

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2032
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. East Asia
- 11.3.5. South Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region

12. North America Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032

12.1. Introduction
12.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis & Forecast By Market Taxonomy, 2024-2032
- 12.3.1. By Country
  - 12.3.1.1. U.S.
  - 12.3.1.2. Canada
- 12.3.2. By Source
- 12.3.3. By Type
- 12.3.4. By Application
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Source
- 12.4.3. By Type
- 12.4.4. By Application
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
- 12.8.1. U.S. Plant-Based Vaccines Market Analysis
  - 12.8.1.1. Introduction
  - 12.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 12.8.1.2.1. By Country
    - 12.8.1.2.2. By Source
    - 12.8.1.2.3. By Type
    - 12.8.1.2.4. By Application
- 12.8.2. Canada Plant-Based Vaccines Market Analysis
  - 12.8.2.1. Introduction
  - 12.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 12.8.2.2.1. By Country
    - 12.8.2.2.2. By Source
    - 12.8.2.2.3. By Type
    - 12.8.2.2.4. By Application

13. Latin America Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032

13.1. Introduction
13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Bn) Analysis & Forecast By Market Taxonomy, 2024-2032
- 13.3.1. By Country
  - 13.3.1.1. Mexico
  - 13.3.1.2. Brazil
  - 13.3.1.3. Argentina
  - 13.3.1.4. Rest of Latin America
    - 13.3.1.4.1. By Country
    - 13.3.1.4.2. By Source
    - 13.3.1.4.3. By Type
    - 13.3.1.4.4. By Application
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Source
- 13.4.3. By Type
- 13.4.4. By Application
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
- 13.8.1. Mexico Plant-Based Vaccines Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 13.8.1.2.1. By Source
    - 13.8.1.2.2. By Type
    - 13.8.1.2.3. By Application
- 13.8.2. Brazil Plant-Based Vaccines Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 13.8.2.2.1. By Country
    - 13.8.2.2.2. By Source
    - 13.8.2.2.3. By Type
    - 13.8.2.2.4. By Application
- 13.8.3. Argentina Plant-Based Vaccines Market Analysis
  - 13.8.3.1. Introduction
  - 13.8.3.2. Market Analysis and Forecast By Market Taxonomy
    - 13.8.3.2.1. By Source
    - 13.8.3.2.2. By Type
    - 13.8.3.2.3. By Application

14. Europe Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032

14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Bn) Analysis & Forecast By Market Taxonomy, 2024-2032
- 14.3.1. By Country
  - 14.3.1.1. Germany
  - 14.3.1.2. Italy
  - 14.3.1.3. France
  - 14.3.1.4. U.K.
  - 14.3.1.5. Spain
  - 14.3.1.6. BENELUX
  - 14.3.1.7. Russia
  - 14.3.1.8. Rest of Europe
- 14.3.2. By Source
- 14.3.3. By Type
- 14.3.4. By Application
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Source
- 14.4.3. By Type
- 14.4.4. By Application
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
- 14.8.1. Germany Plant-Based Vaccines Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.1.2.1. By Source
    - 14.8.1.2.2. By Type
    - 14.8.1.2.3. By Application
- 14.8.2. Italy Plant-Based Vaccines Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.2.2.1. By Source
    - 14.8.2.2.2. By Type
    - 14.8.2.2.3. By Application
- 14.8.3. France Plant-Based Vaccines Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.3.2.1. By Source
    - 14.8.3.2.2. By Type
    - 14.8.3.2.3. By Application
- 14.8.4. U.K. Plant-Based Vaccines Market Analysis
  - 14.8.4.1. Introduction
  - 14.8.4.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.4.2.1. By Source
    - 14.8.4.2.2. By Type
    - 14.8.4.2.3. By Application
- 14.8.5. Spain Plant-Based Vaccines Market Analysis
  - 14.8.5.1. Introduction
  - 14.8.5.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.5.2.1. By Source
    - 14.8.5.2.2. By Type
    - 14.8.5.2.3. By Application
- 14.8.6. BENELUX Plant-Based Vaccines Market Analysis
  - 14.8.6.1. Introduction
  - 14.8.6.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.6.2.1. By Source
    - 14.8.6.2.2. By Type
    - 14.8.6.2.3. By Application
- 14.8.7. Russia Plant-Based Vaccines Market Analysis
  - 14.8.7.1. Introduction
  - 14.8.7.2. Market Analysis and Forecast By Market Taxonomy
    - 14.8.7.2.1. By Source
    - 14.8.7.2.2. By Type
    - 14.8.7.2.3. By Application

15. East Asia Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032

15.1. Introduction
15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Bn) Analysis & Forecast By Market Taxonomy, 2024-2032
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
- 15.3.2. By Source
- 15.3.3. By Type
- 15.3.4. By Application
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Source
- 15.4.3. By Type
- 15.4.4. By Application
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
- 15.8.1. China Plant-Based Vaccines Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 15.8.1.2.1. By Source
    - 15.8.1.2.2. By Type
    - 15.8.1.2.3. By Application
- 15.8.2. Japan Plant-Based Vaccines Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 15.8.2.2.1. By Source
    - 15.8.2.2.2. By Type
    - 15.8.2.2.3. By Application
- 15.8.3. South Korea Plant-Based Vaccines Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast By Market Taxonomy
    - 15.8.3.2.1. By Source
    - 15.8.3.2.2. By Type
    - 15.8.3.2.3. By Application

16. South Asia Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032

16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Bn) Analysis & Forecast By Market Taxonomy, 2024-2032
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Indonesia
  - 16.3.1.3. Malaysia
  - 16.3.1.4. Thailand
  - 16.3.1.5. Rest of South Asia
- 16.3.2. By Source
- 16.3.3. By Type
- 16.3.4. By Application
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Source
- 16.4.3. By Type
- 16.4.4. By Application
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
- 16.8.1. India Plant-Based Vaccines Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 16.8.1.2.1. By Source
    - 16.8.1.2.2. By Type
    - 16.8.1.2.3. By Application
- 16.8.2. Indonesia Plant-Based Vaccines Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 16.8.2.2.1. By Source
    - 16.8.2.2.2. By Type
    - 16.8.2.2.3. By Application
- 16.8.3. Malaysia Plant-Based Vaccines Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast By Market Taxonomy
    - 16.8.3.2.1. By Source
    - 16.8.3.2.2. By Type
    - 16.8.3.2.3. By Application
- 16.8.4. Thailand Plant-Based Vaccines Market Analysis
  - 16.8.4.1. Introduction
  - 16.8.4.2. Market Analysis and Forecast By Market Taxonomy
    - 16.8.4.2.1. By Source
    - 16.8.4.2.2. By Type
    - 16.8.4.2.3. By Application

17. Oceania Plant-Based Vaccines Market 2019-2023 and Forecast 2024-2032

17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Bn) Analysis & Forecast By Market Taxonomy, 2024-2032
- 17.3.1. By Country
  - 17.3.1.1. Australia
  - 17.3.1.2. New Zealand
- 17.3.2. By Source
- 17.3.3. By Type
- 17.3.4. By Application
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Source
- 17.4.3. By Type
- 17.4.4. By Application
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
- 17.7.1. Australia Plant-Based Vaccines Market Analysis
  - 17.7.1.1. Introduction
  - 17.7.1.2. Market Analysis and Forecast By Market Taxonomy
    - 17.7.1.2.1. By Source
    - 17.7.1.2.2. By Type
    - 17.7.1.2.3. By Application
- 17.7.2. New Zealand Plant-Based Vaccines Market Analysis
  - 17.7.2.1. Introduction
  - 17.7.2.2. Market Analysis and Forecast By Market Taxonomy
    - 17.7.2.2.1. By Source
    - 17.7.2.2.2. By Type
    - 17.7.2.2.3. By Application

18. Middle East and Africa (MEA) Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032

18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Bn) Analysis & Forecast By Market Taxonomy, 2024-2032
- 18.3.1. By Country
  - 18.3.1.1. GCC Countries
  - 18.3.1.2. Turkey
  - 18.3.1.3. South Africa
  - 18.3.1.4. North Africa
  - 18.3.1.5. Rest of Middle East and Africa
- 18.3.2. By Source
- 18.3.3. By Type
- 18.3.4. By Application
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Source
- 18.4.3. By Type
- 18.4.4. By Application
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
- 18.8.1. GCC Countries Plant-Based Vaccines Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast By Market Taxonomy
    - 18.8.1.2.1. By Source
    - 18.8.1.2.2. By Type
    - 18.8.1.2.3. By Application
- 18.8.2. Turkey Plant-Based Vaccines Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast By Market Taxonomy
    - 18.8.2.2.1. By Source
    - 18.8.2.2.2. By Type
    - 18.8.2.2.3. By Application
- 18.8.3. South Africa Plant-Based Vaccines Market Analysis
  - 18.8.3.1. Introduction
  - 18.8.3.2. Market Analysis and Forecast By Market Taxonomy
    - 18.8.3.2.1. By Source
    - 18.8.3.2.2. By Type
    - 18.8.3.2.3. By Application
- 18.8.4. North Africa Plant-Based Vaccines Market Analysis
  - 18.8.4.1. Introduction
  - 18.8.4.2. Market Analysis and Forecast By Market Taxonomy
    - 18.8.4.2.1. By Source
    - 18.8.4.2.2. By Type
    - 18.8.4.2.3. By Application

19. Market Structure Analysis

19.1. Market Analysis By Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis (%) of Top Players
19.4. Market Presence Analysis

20. Competition Analysis

20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
- 20.3.1. Creative Biolabs
  - 20.3.1.1. Overview
  - 20.3.1.2. Product Portfolio
  - 20.3.1.3. Sales Footprint
  - 20.3.1.4. Key Financials
  - 20.3.1.5. SWOT Analysis
  - 20.3.1.6. Strategic Overview
- 20.3.2. Medicago Inc.
  - 20.3.2.1. Overview
  - 20.3.2.2. Product Portfolio
  - 20.3.2.3. Sales Footprint
  - 20.3.2.4. Key Financials
  - 20.3.2.5. SWOT Analysis
  - 20.3.2.6. Strategic Overview
- 20.3.3. iBio
  - 20.3.3.1. Overview
  - 20.3.3.2. Product Portfolio
  - 20.3.3.3. Sales Footprint
  - 20.3.3.4. Key Financials
  - 20.3.3.5. SWOT Analysis
  - 20.3.3.6. Strategic Overview
- 20.3.4. ICON
  - 20.3.4.1. Overview
  - 20.3.4.2. Product Portfolio
  - 20.3.4.3. Sales Footprint
  - 20.3.4.4. Key Financials
  - 20.3.4.5. SWOT Analysis
  - 20.3.4.6. Strategic Overview
- 20.3.5. EEA Consulting Engineers
  - 20.3.5.1. Overview
  - 20.3.5.2. Product Portfolio
  - 20.3.5.3. Sales Footprint
  - 20.3.5.4. Key Financials
  - 20.3.5.5. SWOT Analysis
  - 20.3.5.6. Strategic Overview
- 20.3.6. Kentucky BioProcessing, Inc.
  - 20.3.6.1. Overview
  - 20.3.6.2. Product Portfolio
  - 20.3.6.3. Sales Footprint
  - 20.3.6.4. Key Financials
  - 20.3.6.5. SWOT Analysis
  - 20.3.6.6. Strategic Overview
- 20.3.7. Baiya Phytopharm
  - 20.3.7.1. Overview
  - 20.3.7.2. Product Portfolio
  - 20.3.7.3. Sales Footprint
  - 20.3.7.4. Key Financials
  - 20.3.7.5. SWOT Analysis
  - 20.3.7.6. Strategic Overview
- 20.3.8. Protalix Biotherapeutics
  - 20.3.8.1. Overview
  - 20.3.8.2. Product Portfolio
  - 20.3.8.3. Sales Footprint
  - 20.3.8.4. Key Financials
  - 20.3.8.5. SWOT Analysis
  - 20.3.8.6. Strategic Overview